Podcasts about stentrode

Found Gold in France… Top restaurants from You Gov and Stacker... Email: ChewingTheFat@theblaze.com Top 2024 baby names… Max going back to HBO-Max… Last of Us thoughts… Fallout S2 coming in Dec. on Prime… Netflix growing ad tier subscriptions… Nobody 2 out in August… www.blazetv.com/jeffy Promo code: Jeffy… Who Died Today: Rosanna Norton 80… MIT elder care robotics?... Apple & Synchron make Stentrode / brain implant… Google DeepMind unveils AlphaEvolve… See a Man About a Horse… Jokes of The Day… Learn more about your ad choices. Visit megaphone.fm/adchoices

Synchron says the Stentrode can sync your Apple device directly to your brain, allowing people with motor impairment to communicate and handle other tasks more easily. Learn more about your ad choices. Visit podcastchoices.com/adchoices

A vizet pöfögő hidrogénautó csak addig tűnik tisztának, amíg nem tudod, honnan származik az üzemanyaga Telex     2024-10-18 06:02:33     Tudomány Energia Üzemanyag Tankolás A jövő energiahordozójának tartott hidrogén a világegyetem leggyakoribb eleme, ám tiszta formában kevés van belőle, előállítása pedig egyelőre környezetszennyező. Mi kellene ennek megváltozásához? Remény a vesebetegeknek Mínuszos     2024-10-18 07:33:01     Tudomány Oktatás egyetem Portugália Skócia Óbuda Vesebetegeken segíthet az a szoftver és cég, amelyeket magyar kutatók hoztak létre nemzetközi kollégáikkal együtt. A veseelégtelenségben szenvedő betegek számára hozhat minőségi és élhetőbb életet az a szoftver, amelyet az Óbudai Egyetem (OE), a Közgazdaság- és Regionális Tudományi Kutatóközpont (KRTK), valamint portugál és skót kutatók együttműköd Megérkezett a színes kijelzős Amazon Kindle ITBusiness     2024-10-18 06:16:32     Mobiltech Amazon Az Amazon bemutatta az első színes Kindle-t, ami elég ígéretesnek tűnik. A készülék neve "Kindle Colorsoft Signature Edition", és sok szempontból hasonlít a nemrégiben megjelent Kindle Paperwhite-ra. A 279,99 dolláros olvasó már előrendelhető, a szállítások október 30-án kezdődnek. Az Amazon szerint a színes kijelző létrehozása több technológiai ki Ez most Európa legértékesebb techcége Igényesférfi.hu     2024-10-18 04:34:10     Infotech Hollandia Holding Eddig az ASML Holding nevű holland chipgyártóé volt a megtisztelő titulus, ám a napokban trónfosztás történt, és piaci kapitalizációja alapán egy német szoftvercég került az első helyre. Kiderült a legrejtélyesebb barna törpe 30 éves titka Rakéta     2024-10-18 11:33:04     Tudomány Világűr Az 1995-ben felfedezett Gliese 229 B egyike az első ismert barna törpéknek, amelynek óriási volt a csillagászati jelentősége. Ennek ellenére akadt egy megmagyarázhatatlan rejtély vele kapcsolatban – egészen mostanáig. Hála ugyanis a modern eszközöknek kiderült végre a Gliese 229 B titka. 2027-ig a szoftvermérnökök négyötödének át kell képeznie magát ICT Global     2024-10-18 06:03:09     Infotech Mesterséges intelligencia A mesterséges intelligencia, különösen a generatív MI gyors fejlődése megváltoztatja a szoftvermérnöki munkát. Szerencsére nem úgy, ahogy sokan félik, mert nem állásokat vesz át, hanem a dolgozókat továbbképzésre készteti. Nem tehetnek mást, mert különben lemaradnak, és a jövőben egyébként sem nagyon lesznek MI nélküli szoftverek. A Bosch és a Richter Gedeon ipari innovációs díját nyerte el a Széchenyi István Egyetem két hallgatója Helló Sajtó!     2024-10-18 06:34:34     Tudomány Oktatás egyetem Győr Innováció Richter Bosch Olyan, mesterségesintelligencia-modellekre épülő megoldást fejlesztett ki a győri Széchenyi István Egyetem két hallgatója, Lőrincz Fanni és Szőnyi Balázs, amellyel a felhasználó úgy tud beszélgetni, mint egy élő emberrel. Céljuk elsősorban a társadalmilag elszigetelődött emberek és a pszichés betegségekkel élők segítése, valamint az ilyen betegsége Rejtélyes kincsekre bukkantak fémkeresővel 24.hu     2024-10-18 14:29:13     Tudomány Senki nem tudja, miért és hogyan kerülhettek a ritka tárgyak a német település közelébe. Ocsmányságokat kiabáltak gazdáikra a meghekkelt robotporszívók Bitport     2024-10-18 07:59:00     Infotech Robot Hacker A támadók egy primitív hibát kihasználva vehették át az uralmat a kamerával is felszerelt gépek fölött, a javítást viszont nem sieti el senki. IT közösséget épít a Budapestre érkező Puzl CowOrKing Márkamonitor     2024-10-18 07:06:02     Infotech Sokan még mindig azt hiszik, hogy a coworking egyenlő azzal, hogy digitális nomádok és szabadúszók bérelnek íróasztalokat. A coworking piac ehelyett egyre inkább a teljes körű és specializált szolgáltatást nyújtó, rugalmas munkaterületek felé mozdul el.   "Egyre inkább azt tapasztaljuk, hogy a nagyobb It cégek is nagyra becsülik ezeket az all-inclu Videón az üstökös, amit ember még nem láthatott, és legközelebb 80 ezer év múlva lesz rá újból esély Player     2024-10-18 04:57:01     Tudomány Világűr Az üstökös először jár a Naprendszer belső régióiban. Synchron agyimplantátum – Amikor majd a gondolat vezérel PlanetZ     2024-10-18 08:00:38     Tudomány Apple Elon Musk Amazon A Synchron Stentrode agy-számítógép interfész (BCI) megelőzte Elon Musk Neuralinkjét. A Stentrode kevésbé invazív módszerrel az agy véredényein keresztül vezeti be technológiáját, amely már most képes okoseszközök, mint az Amazon Alexa és az Apple Vision Pro, gondolati irányítására. Bebizonyították, hogy a mesterséges intelligenciák még az iskolás matekfeladatokat sem "értik" Rakéta     2024-10-18 14:06:07     Infotech Mesterséges intelligencia Iskolakezdés Apple Az Apple mérnökeinek egy tanulmánya világít rá arra, hogy ami gondolkodásnak tűnik, nem feltétlenül az. A további adásainkat keresd a podcast.hirstart.hu oldalunkon.

A vizet pöfögő hidrogénautó csak addig tűnik tisztának, amíg nem tudod, honnan származik az üzemanyaga Telex     2024-10-18 06:02:33     Tudomány Energia Üzemanyag Tankolás A jövő energiahordozójának tartott hidrogén a világegyetem leggyakoribb eleme, ám tiszta formában kevés van belőle, előállítása pedig egyelőre környezetszennyező. Mi kellene ennek megváltozásához? Remény a vesebetegeknek Mínuszos     2024-10-18 07:33:01     Tudomány Oktatás egyetem Portugália Skócia Óbuda Vesebetegeken segíthet az a szoftver és cég, amelyeket magyar kutatók hoztak létre nemzetközi kollégáikkal együtt. A veseelégtelenségben szenvedő betegek számára hozhat minőségi és élhetőbb életet az a szoftver, amelyet az Óbudai Egyetem (OE), a Közgazdaság- és Regionális Tudományi Kutatóközpont (KRTK), valamint portugál és skót kutatók együttműköd Megérkezett a színes kijelzős Amazon Kindle ITBusiness     2024-10-18 06:16:32     Mobiltech Amazon Az Amazon bemutatta az első színes Kindle-t, ami elég ígéretesnek tűnik. A készülék neve "Kindle Colorsoft Signature Edition", és sok szempontból hasonlít a nemrégiben megjelent Kindle Paperwhite-ra. A 279,99 dolláros olvasó már előrendelhető, a szállítások október 30-án kezdődnek. Az Amazon szerint a színes kijelző létrehozása több technológiai ki Ez most Európa legértékesebb techcége Igényesférfi.hu     2024-10-18 04:34:10     Infotech Hollandia Holding Eddig az ASML Holding nevű holland chipgyártóé volt a megtisztelő titulus, ám a napokban trónfosztás történt, és piaci kapitalizációja alapán egy német szoftvercég került az első helyre. Kiderült a legrejtélyesebb barna törpe 30 éves titka Rakéta     2024-10-18 11:33:04     Tudomány Világűr Az 1995-ben felfedezett Gliese 229 B egyike az első ismert barna törpéknek, amelynek óriási volt a csillagászati jelentősége. Ennek ellenére akadt egy megmagyarázhatatlan rejtély vele kapcsolatban – egészen mostanáig. Hála ugyanis a modern eszközöknek kiderült végre a Gliese 229 B titka. 2027-ig a szoftvermérnökök négyötödének át kell képeznie magát ICT Global     2024-10-18 06:03:09     Infotech Mesterséges intelligencia A mesterséges intelligencia, különösen a generatív MI gyors fejlődése megváltoztatja a szoftvermérnöki munkát. Szerencsére nem úgy, ahogy sokan félik, mert nem állásokat vesz át, hanem a dolgozókat továbbképzésre készteti. Nem tehetnek mást, mert különben lemaradnak, és a jövőben egyébként sem nagyon lesznek MI nélküli szoftverek. A Bosch és a Richter Gedeon ipari innovációs díját nyerte el a Széchenyi István Egyetem két hallgatója Helló Sajtó!     2024-10-18 06:34:34     Tudomány Oktatás egyetem Győr Innováció Richter Bosch Olyan, mesterségesintelligencia-modellekre épülő megoldást fejlesztett ki a győri Széchenyi István Egyetem két hallgatója, Lőrincz Fanni és Szőnyi Balázs, amellyel a felhasználó úgy tud beszélgetni, mint egy élő emberrel. Céljuk elsősorban a társadalmilag elszigetelődött emberek és a pszichés betegségekkel élők segítése, valamint az ilyen betegsége Rejtélyes kincsekre bukkantak fémkeresővel 24.hu     2024-10-18 14:29:13     Tudomány Senki nem tudja, miért és hogyan kerülhettek a ritka tárgyak a német település közelébe. Ocsmányságokat kiabáltak gazdáikra a meghekkelt robotporszívók Bitport     2024-10-18 07:59:00     Infotech Robot Hacker A támadók egy primitív hibát kihasználva vehették át az uralmat a kamerával is felszerelt gépek fölött, a javítást viszont nem sieti el senki. IT közösséget épít a Budapestre érkező Puzl CowOrKing Márkamonitor     2024-10-18 07:06:02     Infotech Sokan még mindig azt hiszik, hogy a coworking egyenlő azzal, hogy digitális nomádok és szabadúszók bérelnek íróasztalokat. A coworking piac ehelyett egyre inkább a teljes körű és specializált szolgáltatást nyújtó, rugalmas munkaterületek felé mozdul el.   "Egyre inkább azt tapasztaljuk, hogy a nagyobb It cégek is nagyra becsülik ezeket az all-inclu Videón az üstökös, amit ember még nem láthatott, és legközelebb 80 ezer év múlva lesz rá újból esély Player     2024-10-18 04:57:01     Tudomány Világűr Az üstökös először jár a Naprendszer belső régióiban. Synchron agyimplantátum – Amikor majd a gondolat vezérel PlanetZ     2024-10-18 08:00:38     Tudomány Apple Elon Musk Amazon A Synchron Stentrode agy-számítógép interfész (BCI) megelőzte Elon Musk Neuralinkjét. A Stentrode kevésbé invazív módszerrel az agy véredényein keresztül vezeti be technológiáját, amely már most képes okoseszközök, mint az Amazon Alexa és az Apple Vision Pro, gondolati irányítására. Bebizonyították, hogy a mesterséges intelligenciák még az iskolás matekfeladatokat sem "értik" Rakéta     2024-10-18 14:06:07     Infotech Mesterséges intelligencia Iskolakezdés Apple Az Apple mérnökeinek egy tanulmánya világít rá arra, hogy ami gondolkodásnak tűnik, nem feltétlenül az. A további adásainkat keresd a podcast.hirstart.hu oldalunkon.

Alan interviews Nick Opie. Professor Nick Opie was interested in devices to help paralysis patients. He invented Stentrode, a revolutionary brain-computer interface that allows paralysis patients to use their thoughts to send texts and emails.  Unlike competitor devices, Stentrode requires no invasive, risky open brain surgery. Make sure to subscribe to the podcast at Apple Podcasts, or wherever you get your podcasts, so you won't miss a single episode. Website: www.Synchron.com  

Breakthroughs in artificial intelligence and neurotechnology are revolutionizing healthcare, enabling people with debilitating diseases to communicate in ways previously impossible. Implantable devices like the Stentrode, developed by Synchron, can translate brain signals into physical actions, giving patients like Rodney, who has ALS, the ability to type using only his thoughts. As the neurotech market grows, projected to reach $55 billion by 2032, companies like Meta and Apple are investing in non-invasive devices to decode thoughts and perceptions, but concerns over mental privacy are driving calls for regulation and policy change. --- Send in a voice message: https://podcasters.spotify.com/pod/show/tonyphoang/message

Après l'IA, voici venu le temps de la compétition pour dominer les neurotechnologies ! Si Elon Musk en est le pionnier aux yeux du grand public avec Neuralink, dont l'un des objectifs est de rendre leur mobilité aux personnes paralysées via un implant dans le cerveau, d'autres grandes fortunes de la tech ont également investi des millions dans ce domaine. C'est le cas de Bill Gates, fondateur de Microsoft, et de Jeff Bezos, figure incontournable d'Amazon, qui n'ont pas hésité à donner des millions de dollars à Synchron, une jeune entreprise qui ambitionne, comme Neuralink, de nous implanter des puces dans le cerveau, mais grâce à un procédé moins invasif.Pour l'historique, Synchro est une jeune entreprise new-yorkaise fondée en 2016 par le docteur Tom Oxley. En se positionnant comme rivale de Neuralink, l'entreprise a déjà réussi à amasser 140 millions de dollars. Elle a même vu la DARPA, une agence fédérale américaine spécialisée dans la recherche militaire, lui octroyer un financement. Pour rappel, Neuralink se base sur la technologie dite « Interface Cerveau-Ordinateur » pour développer le dispositif Telepathy, conçu pour « connecter des cerveaux humains directement à des ordinateurs ». Si l'on en croit Elon Musk, Neuralink ira même bien au-delà de cette seule mission de redonner du mouvement aux personnes handicapées à l'avenir, puisqu'il est convaincu que sa puce permettra à certains individus de communiquer par télépathie, aux aveugles de retrouver la vue, et carrément de fusionner l'esprit humain avec l'intelligence artificielle. Synchron, de son côté, adopte une approche différente avec sa micropuce Stentrode, poussée à travers un vaisseau sanguin jusqu'au cerveau du patient via un cathéter.En clair, l'entreprise du docteur Oxley veut montrer que Neuralink n'est pas la seule à briller dans le domaine de la neuretechnologie. La start-up veut utiliser des stents pour implanter ses puces cérébrales. La méthode, bien moins invasive, est jusque-là surtout réservée à la cardiologie et à la chirurgie vasculaire. Le stent peut être comparé à un petit ressort en métal de quelques millimètres de diamètre seulement. La technologie éprouvée par Synchron fait toutefois face à certains défis. L'utilisation de stents peut en effet entraîner davantage de « bruit » dans la lecture des signaux cérébraux, ce qui peut en limiter la précision. Que ce soit à travers Neuralink ou Synchron, ces avancées transformeront peut-être un jour notre manière d'interagir avec la technologie. Hébergé par Acast. Visitez acast.com/privacy pour plus d'informations.

What if you could control your digital devices using just the power of thought? That's the incredible promise behind the Stentrode — an implantable brain-computer interface that collects and wirelessly transmits information directly from the brain, without the need for open surgery. Neurotech entrepreneur Tom Oxley describes the intricacies of this breakthrough technology, which is currently enrolling participants in human trials, as well as how it could help restore dignity to those with disabilities — and transform the future of communication. Stay tuned after the talk to hear our host Sherrell talk about the promise and potential of technology when it comes to serving one of humanity's greatest needs: connection.

Kurt Haggestrom comes on to talk about the latest new from Synchron, which has developed the Stentrode as well as the new Synchron Switch. Kurt talks about his new role as Chief Commercial Officer and where the company is heading. ***This podcast is sponsored by CEITEC Nano, check out their Neurotech Device Manufacturing Capabilities here*** Top three takeaways:  1. "The beauty of this approach is that the blood vessels are an amazing place. To be able to put implants and we've, we're leveraging really decades of science and medical devices in say, the coronary space and the heart space. We know that these types of materials heal very well within the vasculature. It's a very novel approach and really scalable because there's a lot of physicians that can do this type of procedure."  2.   "Syncron is developing we're calling it the Synch Switch. So it is an endovascular brain-computer interface system. This system will allow patients who are suffering from paralysis to connect into the digital world, whether it's banking, communication by using a smartphone or computer.  3. "A key part of, I think these types of novel technologies is to think about "how do people afford this when it does get to market?" And with the patients that we're focused on today, many of them use Medicare to be able to afford these technologies. It's critical that we think about our partnership and in working with CMOs to make reimbursement possible for these type of technologies.   [1:15] "Do you want to give a refresher on what Synchron does?" [3:00]  "What are some exciting news that comes out of Synchron?" [4:15] "So what is Chief Commercialization Officer and why is it necessary, especially for a company like Syncron which isn't commercial yet?" [5:45] CEITEC Nano ad sponsorship [6:15] "What's your story arc?" [8:30] How are you navigating reimbursement? [9:30] What is your timeline for commercialization? [10:45] "What are some security protocols, that you're putting into place?" [12:30] "What are some of your biggest challenges nowadays?"  [16:15] How many patients were in your study? [16:30] How large is the target market? [18:15] Does this have other application potentials outside of locked in patients? [19:15] "Is there anything that we didn't talk about that you wanted to mention?"    

Tom Oxley is building what he calls a “natural highway into the brain” that lets people use their minds to control their phones and their computers. The device, called the Stentrode, could improve the lives of hundreds of thousands of people living with spinal cord paralysis, ALS and other neuro degenerative diseases.Leaps.org talked with Dr. Oxley for today's podcast. A fascinating thing about the Stentrode is that it works very differently from other “brain computer interfaces” you may be familiar with, like Elon Musk's Neuralink. Surgeons implant the some BCIs directly into a person's brain, but the Stentrode is much less invasive. Dr. Oxley's company Synchron opts for an ingenious “natural” approach, using stents in blood vessels to access the brain, with some major advantages for a handful of people who've already started using the Stentrode.  The audio improves about 10 minutes in. There was a minor headset issue early on but everything is audible throughout. In our conversation, Dr. Oxley talks about what it means to have a “Bluetooth brain,” the critical role played by AI in the present and future of BCIs, how BCIs compare to voice command technology, regulatory frameworks for revolutionary technologies, specific people with paralysis who've been able to regain some of their independence thanks to the Stentrode, what it means to be a neurointerventionist, how to scale BCIs so that more people can use them, the risks of BCIs malfunctioning, organic implants, and how BCIs help us understand the brain, among other topics. Dr. Oxley received his PhD in neuro engineering from the University of Melbourne in Australia. He is the founding CEO of Synchron and an associate professor and head of the vascular bionics laboratory at the University of Melbourne. He's also a clinical instructor in the Deepartment of Neurosurgery at Mount Sinai Hospital. He's completed more than 1,600 endovascular neurosurgical procedures on patients, including those with aneurysms and strokes, and has authored over 100 peer reviewed articles. Dr. Oxley's work opens up game-changing opportunities for many patients, and his views on the present and future of BCIs are must listening for anyone who cares about health and technology.  Links:Synchron - https://synchron.com/ Tom Oxley social links https://www.linkedin.com/in/tomoxlhttps://twitter.com/tomoxl?lang=en Tom Oxley TED talk and website  https://www.ted.com/talks/tom_oxley_a_brain_implant_that_turns_your_thoughts_into_text?language=en https://tomoxl.com/ Novel brain implant helps paralyzed woman speak using digital avatar - https://engineering.berkeley.edu/news/2023/08/novel-brain-implant-helps-paralyzed-woman-speak-using-a-digital-avatar/ Edward Chang lab - https://changlab.ucsf.edu/ BCIs convert brain activity into text at 62 words per minute - https://med.stanford.edu/neurosurgery/news/2023/henderson-brain-implant-speech-alsLeaps.org is a not-for-profit initiative that publishes award-winning journalism, popularizes scientific progress on social media, and hosts events about bioethics and the future of humanity. Visit the platform at www.leaps.org. Podcast host Matt Fuchs is editor-in-chief of Leaps.org.

Alan interviews Nick Opie. Professor Nick Opie was interested in devices to help paralysis patients. He invented Stentrode, a revolutionary brain-machine interface that allows paralysis patients to use their thoughts to send texts and emails. Unlike competitor devices, Stentrode requires no invasive, risky open brain surgery. Make sure to subscribe to the podcast at Apple Podcasts, or wherever you get your podcasts, so you won't miss a single episode. Website: www.Synchron.com  

Hasta ahora, las interfaces cerebro-computadora se han probado principalmente en el campo de la medicina. Pero los precursores saben que su tecnología tendrá infinidad de aplicaciones.

La interfaz cerebro-computadora de la start-up australiana Synchron permite enviar un e-mail solo con el pensamiento. Así, personas con ELA u otras enfermedades severas del sistema nervioso pueden comunicarse.

Bislang werden Brain-Computer-Interfaces überwiegend für Menschen mit Behinderung getestet. Aber Tech-Vordenker träumen schon von einer Art implantierten Gehirnsteuerung, die in verschiedenen Bereiche Anwendung findet.

So far, brain-computer interfaces have been tested mainly for people with disabilities. But tech companies are already dreaming up brain implants that could be used in a variety of fields.

A brain-computer interface developed by Australian startup Synchron allows a person to send an email with their thoughts alone. It's given patients with advanced neurological diseases like ALS a new way to communicate.

Eine E-Mail allein mithilfe von Gedanken verschicken, dank des Brain-Computer-Interfaces des australischen Start-ups Synchron. So können auch Menschen mit der weit fortgeschrittenen Nervenkrankheit ALS kommunizieren.

Welcome to Neurocareers, the podcast that proves the impossible is possible! We're thrilled to bring you the second episode of our BCI Award Neurocareers series featuring Prof. Nicholas Opie, the mastermind behind the revolutionary Stentrode and endovascular neural interfaces. Prof. Opie, a biomedical engineer and the founding CTO of Synchron, knows what it takes to succeed in the innovative field of neurotech. Prof. Opie's Stentrode project won 1st place in the International BCI Award competition in 2021. In this podcast episode, he'll share his top tips for winning the International BCI Award and building a successful career in the industry. Join us as we dive deep into the Stentrode revolution and discover how endovascular neural interfaces are changing the game. Prof. Opie will take us through his groundbreaking research and share insights on making the impossible possible in neurotech. As always, Neurocareers inspires and educates you on the exciting and ever-evolving world of neuroscience and neurotechnologies. Don't miss this opportunity to learn from one of the best in the field! This BCI Award Neurocareers series is a partnership between Milena Korostenskaja, PhD at the Institute of Neuroapproaches, and Christoph Guger, PhD at g.tec biomedical engineering. About the Podcast Guest: Professor Nicholas Opie, BE BSc PhD MBA, is a leading biomedical engineer and an expert in neural interfaces. He currently serves as the Laboratory Head of the Vascular Bionics Laboratory in the Department of Medicine at the University of Melbourne, where he is also an NHMRC Research Fellow. Throughout his career, Prof Opie has brought multiple biomedical devices from concept to clinic, including a suprachoroidal retinal prosthesis (bionic eye) that aims to restore vision to individuals with profound vision loss, and a motor neuron prosthesis (bionic spine) that seeks to restore independence, communication, and mobility to individuals with paralysis. He has published over 55 peer-reviewed journal articles, including in Nature Biomedical Engineering and Nature Biotechnology. Additionally, he has filed over 90 patents and was awarded the 2021 NFMRI John Raftos AM Award for Advancing Innovation. Prof Opie is also Synchron's founding Chief Technology Officer (CTO), a neural interface company based in Melbourne and New York. He has raised over AUD$210M in private funding and grants and designed Synchron's flagship product, the Stentrode™. The Stentrode is listed in Time Magazine's Top 100 Inventions of 2021 and aims to provide treatment for debilitating medical illnesses while empowering patients by reconnecting them online in ways that dramatically improve their lives. Following a successful first-in-human trial conducted in Australia on the Stentrode motor neuroprosthesis, Prof Opie and Synchron recently received approval from the US FDA. This approval paves the way for a trial in the US, which will commence this year and represents a significant step towards the first FDA approval for implantable brain-computer interfaces. To learn more about Prof Opie and his work, visit his profile page at the University of Melbourne: https://findanexpert.unimelb.edu.au/profile/430403-nicholas-opie. You can also check out the Stentrode SWITCH study, which involved four patients: https://pubmed.ncbi.nlm.nih.gov/36622685/. Learn more about Synchron's innovative technology on their website: https://synchron.com/. Finally, connect with Prof Nicholas Opie on LinkedIn: https://www.linkedin.com/in/professor-nicholas-opie-4603289a/. About the podcast host: The Neurocareers podcast is brought to you by The Institute of Neuroapproaches (https://www.neuroapproaches.org/) and its founder, Milena Korostenskaja, Ph.D. (Dr. K), a neuroscience educator, research consultant, and career coach for students and recent graduates in neuroscience and neurotechnologies. As a professional coach with a background in the field, Dr. K understands the unique challenges and opportunities facing students in this field and can provide personalized coaching and support to help you succeed. Here's what you'll get with one-on-one coaching sessions from Dr. K: Identification and pursuit of career goals Guidance on job search strategies, resume and cover letter development, and interview preparation Access to a network of professionals in the field of neuroscience and neurotechnologies Ongoing support and guidance to help you stay on track and achieve your goals You can always schedule a free neurocareer consultation/coaching session with Dr. K at https://neuroapproaches.as.me/free-neurocareer-consultation Subscribe to our Nerocareers Newsletter to stay on top of all our cool neurocareers news at updates https://www.neuroapproaches.org/neurocareers-news  

00:00 Intro 00:33 FDA human trials application 02:22 Synchron's Stentrode device 04:38 Neuralink's Patient Registry 04:59 Perri Karyal gaming w/ EEG 05:53 Elon discusses VR on Babylon Bee 06:59 Dr. Paul Nuyujukian analyzes Neuralink 08:57 Other BCI news 10:19 Kernel, Bryan Johnson, Project Blueprint 10:53 James Douma Interviews 15:34 Neuralink is hiring Perri Karyal Gaming: https://twitter.com/JakeSucky/status/1618275174444593152?s=20 Elon Tweet (FDA Acronym poll): https://twitter.com/elonmusk/status/1632524437227716608?t=ouyMu9uz8xjq6QTQbqOyvw&s=03 Elon Tweet (SEC Acronym): https://twitter.com/elonmusk/status/1278764736876773383?s=20 Comparing Utah Array & DBS to Neuralink: https://www.youtube.com/live/r-vbh3t7WVI?feature=share&t=1578 First indications: https://www.youtube.com/live/YreDYmXTYi4?feature=share&t=1950 Monkey MindPong Deconstructed: https://youtu.be/rzNOuJIzk2E?t=240 Neuralink tweet (freshly baked chips): https://twitter.com/neuralink/status/1633243406368493569?s=20 Neuralink tweet (monkey business): https://twitter.com/neuralink/status/1635763304562827265?s=20 DJ Seo and BCI leaders: https://www.linkedin.com/posts/jojoplatt_bci-bci-activity-7032067751993085952-Qg99/?utm_source=share&utm_medium=member_desktop Kernel announcement: Dr. Ryan Field promoted to CEO: https://www.linkedin.com/posts/kernel_precisionmedicine-neuroscience-neurotech-activity-7038912240581832704-oonN/ Bryan Johnson's Project Blueprint: https://medium.com/future-literacy/project-blueprint-360eaf1d8ea2 Neuralink tweet (surgery demonstration): https://twitter.com/neuralink/status/1638299507422113792?s=20 Patient Registry: https://neuralink.com/patient-registry/ Careers: https://neuralink.com/careers/ Neura Pod is a series covering topics related to Neuralink, Inc. Topics such as brain-machine interfaces, brain injuries, and artificial intelligence will be explored. Host Ryan Tanaka synthesizes information, shares opinions, and conducts interviews to easily learn about Neuralink and its future. Twitter: https://www.twitter.com/ryantanaka3/ Support: https://www.patreon.com/neurapod/ Please consider supporting by joining the channel above, or sharing my other company website with retirees: https://www.reterns.com/. Opinions are my own. Neura Pod receives no compensation from Neuralink and has no affiliation to the company. #Neuralink #ElonMusk #Tesla --- Support this podcast: https://podcasters.spotify.com/pod/show/neura-pod/support

This week, we're taking a look at the brain and a world-changing idea that could overhaul how we approach brain surgery. A company called Synchron is investigating how you restore, treat, and map the electrical activities of the human brain. And they've developed the first brain-computer-interface implant in the United States. It's called a Stentrode, and when the device gets implanted, it can allow severely paralyzed patients to control personal devices without using their hands. Producer Avery Miles sat down with Peter Yoo, Synchron's director of Neuroscience, at last year's Fast Company Innovation Festival to learn more about how this technology works.

What if you could control digital devices using just the power of thought? That's the incredible promise behind the Stentrode -- an implantable brain-computer interface that collects and wirelessly transmits information directly from the brain, without the need for open surgery. Neurotech entrepreneur Tom Oxley describes the intricacies of this breakthrough technology, which is currently enrolling participants in human trials, as well as how it could help restore dignity to those with disabilities -- and transform the future of communication. After the talk, Shoshana shares a brief but informative lesson on the prevalence and history of Sign Language.

Episode 21  |  Please Subscribe!!On this episode we discuss Georgi's first time on the golf course, the ups & downs, we go through what we believe is the top 10 electric personal vehicles and the latest in news from Connor McGregor, Hasbullah, Bugatti, Neuralink and more. Space Invaders is a new show featuring your hosts Georgi & Trosk, we discuss current events, pop-culture, mental health ,our experiences and adventures. Join us on our journey as we analyse the world through different perspectives and with a comedic and sometimes controversial outlook.Instagram: https://www.instagram.com/spaceinvaders.tv/TikTok: https://www.tiktok.com/@spaceinvaders.tvSupport the show

"What if you could control digital devices using just the power of thought? That's the incredible promise behind the Stentrode -- an implantable brain-computer interface that collects and wirelessly transmits information directly from the brain, without the need for open surgery. Neurotech entrepreneur Tom Oxley describes the intricacies of this breakthrough technology, which is currently enrolling participants in human trials, as well as how it could help restore dignity to those with disabilities -- and transform the future of communication. This is an episode of TED Tech. Stay tuned after the talk to hear host Sherrell Dorsey talk about the promise and potential of technology when it comes to serving one of humanity's greatest needs: connection. For more ideas on the intersection of tech and humanity, follow TED Tech wherever you're listening to this. "

What if you could control your digital devices using just the power of thought? That's the incredible promise behind the Stentrode -- an implantable brain-computer interface that collects and wirelessly transmits information directly from the brain, without the need for open surgery. Neurotech entrepreneur Tom Oxley describes the intricacies of this breakthrough technology, which is currently enrolling participants in human trials, as well as how it could help restore dignity to those with disabilities -- and transform the future of communication. Stay tuned after the talk to hear our host Sherrell talk about the promise and potential of technology when it comes to serving one of humanity's greatest needs: connection.

In this episode of Med Tech Talks, Robert Klupacs CEO of the Bionics Institute, a world leader in the development of medical devices, talks to CEO of Synchron about the persistence and perspiration needed to build an innovative idea into a thriving med tech start-up, and gives advice to fellow entrepreneurs.This series is dedicated to understanding what drives successful and impactful innovation in medical technology, and you would be hard-pressed to find someone as fitting for us to have as a guest on this podcast than Associate Professor Tom Oxley, who kindly joined us from New York. As well as being a renowned interventional neurologist at Mount Sinai Hospital in New York, Tom is the founder and CEO of Synchron, a company that specialises in neural interface technology.  Synchron was born from Tom's great innovation, the Stentrode, an implantable medical device that can translate brain thought signals from the inside of a blood vessel.  Thoughts captured from users of the stentrode are translated wirelessly digital devices designed to stimulate thought-controlled movement, which could transform the lives of people who are paralysed or have severely restricted movement. In this episode you will hear about:The story of SynchronSourcing start-up funding and tips for people in med techTom's thoughts on building Australia from innovation More informationTake a look at the Synchron website: www.synchron.com To find out more about commercialisation of research through medical device spin-off companies at the Bionics Institute, go to: Our Impact  Updated version 05/08/22

What if you could control digital devices using just the power of thought? That's the incredible promise behind the Stentrode -- an implantable brain-computer interface that collects and wirelessly transmits information directly from the brain, without the need for open surgery. Neurotech entrepreneur Tom Oxley describes the intricacies of this breakthrough technology, which is currently enrolling participants in human trials, as well as how it could help restore dignity to those with disabilities -- and transform the future of communication.

What if you could control digital devices using just the power of thought? That's the incredible promise behind the Stentrode -- an implantable brain-computer interface that collects and wirelessly transmits information directly from the brain, without the need for open surgery. Neurotech entrepreneur Tom Oxley describes the intricacies of this breakthrough technology, which is currently enrolling participants in human trials, as well as how it could help restore dignity to those with disabilities -- and transform the future of communication.

What if you could control digital devices using just the power of thought? That's the incredible promise behind the Stentrode -- an implantable brain-computer interface that collects and wirelessly transmits information directly from the brain, without the need for open surgery. Neurotech entrepreneur Tom Oxley describes the intricacies of this breakthrough technology, which is currently enrolling participants in human trials, as well as how it could help restore dignity to those with disabilities -- and transform the future of communication.

Andy and Dave discuss the latest in AI news and research, starting with the European Parliament adopting the final recommendations of the Special Committee on AI in a Digital Age (AIDA), finding that the EU should not always regulate AI as a technology, but use intervention proportionate to the type of risk, among other recommendations [1:31]. Synchron enrolled the first patient in the U.S. clinical trial of its brain-computer interface, Stentrode, which does not require drilling into the skull or open brain surgery; it is, at present, the only company to receive FDA approval to conduct clinical trials of a permanently implanted BCI [4:14]. MetaAI releases its 175B parameter transformer for open use, Open Pre-trained Transformers (OPT), to include the codebase used to train and deploy the model, and their logbook of issues and challenges [6:25].  In research, DeepMind introduces Gato, a “single generalist agent,” which with a single set of weights, is able to complete over 600 tasks, including chatting, playing Atari games, captioning images, and stacking blocks with a robotic arm; one DeepMind scientist used the results to claim that “the game is over” and it's all about scale now, to which others that using massive amounts of data as a substitute for intelligence is perhaps “alt intelligence [8:48].” In the opinion essay of the week, Steve Johnson pens “AI is mastering language, should we trust what it says [18:07]?” Daedalus's Spring 2022 issue focuses on AI and Society, with nearly 400 pages and over 25 essays on a variety of AI-related topics [19:06]. And finally, Professor Ido Kanter from Bar-Ilan University joins to discuss his latest neuroscience research, which suggests a new model for how neurons learn, using dendritic branches [20:48]. RSVP for AI and National Security: Gender, Race, and Algorithms at 12:00 pm on June 7. Apply: Sr. Research Specialist (Artificial Intelligence Research) - ESDA Division Further Reading

The end of the telehealth era? The Gig Economy Worker—A New Social Determinant of Health? A man who got 12 COVID booster shots? Omicron's silver lining? All the relevant stories are linked below: Non-COVID-19 Stories: The Gig Economy Worker—A New Social Determinant of Health? Elizabeth Holmes verdict: Former Theranos CEO is found guilty on 4 counts The telehealth bubble has burst. Time to figure out what's next Synchron Announces First Direct-Thought Tweet, “Hello World,” Using an Implantable Brain Computer Interface: A patient with ALS in Australia is the first person to tweet a message to the world using only direct thought via the Stentrode™ brain computer interface. COVID-19 Stories: Hospitals Are in Serious Trouble: Omicron is inundating a health-care system that was already buckling under the cumulative toll of every previous surge. Will the Omicron Wave Break Nursing?: A lot has changed since the beginning of the pandemic when there were more than 3,000 patients in intensive care units at New York City hospitals and upwards of 750 people were dying a day from COVID. Omicron could have a silver lining by boosting immunity, some experts say. But don't bet on it.: They note that omicron, while stunningly contagious, appears less likely to send someone to the hospital. How Full Are Hospital I.C.U.s Near You?: About one in 4 U.S. hospitals with intensive care units, or 713 total hospitals, recently reported that at least 95 percent of their I.C.U. beds were full. In the week ending Dec. 30, an average of 77 percent of intensive care hospital beds were occupied nationwide, according to a dataset released weekly by the Department of Health and Human Services. Dr. Robert Malone on Joe Rogan's Podcast (FACT CHECK): Who is Robert Malone? Joe Rogan's guest was a vaccine scientist, became an anti-vaccine darling What Is Mass Formation Psychosis? Robert Malone Makes Unfounded Covid-19 Vaccine Claims On Joe Rogan Show

Australian company Synchron has developed a brain chip called the Stentrode that helps people with paralysis communicate by controlling digital devices with their thoughts.  The groundbreaking medical device is implanted into the motor cortex without open brain surgery. It has been trialed successfully with several Australian patients and is the first device to be approved by the FDA for a US clinical trial starting later this year. The project is making headlines around the world and is funded through MTPConnect's BioMedTech Horizons program, an MRFF initiative. We catch up with the founders - Associate Professor Thomas Oxley, Synchron's Chief Executive Officer, Vascular and Interventional Neurologist at Mount Sinai Hospital in New York City, and co-head of the Vascular Bionics Laboratory at the University of Melbourne, Australia and Associate Professor Nicholas Opie, Synchron's Chief Technology Officer and co-head of the Vascular Bionics Laboratory at the University of Melbourne, Australia. www.synchron.com 

Thomas Oxley is a neurosurgeon who is also the founder of Synchron which makes the Stentrode. Instead of requiring invasive brain surgery for implantable neural devices, they are able to use stents such as those used in cardiology to collect neural signals   Top 3 Takeaways: Stentrode implantation it's one of the simplest stent procedures. Got a $40 million Series B funding round from Khosla Ventures thanks to the success of in-human studies as well as the potential to piggyback off of existing hospital technologies "We see an avenue for a range of products that do not require open brain surgery that reaches all regions of the brain, that can take information out, that can take information in that are fully implanted, that is easy to put in, and that should open up a new industry to solve problems that haven't otherwise been able to be solved." 2:00 "Do you want to describe the technology?" 5:15 "What is the level of skill required for an implant of a stent?" 6:45 "How did you come up with this technology?" 9:00 "You cold-called DARPA to get funding?" 12:15 "Our device is meant to be encapsulated and so it is a benefit for us, so how did that work?" 15:00 "And then you guys got a breakthrough status in August. Do you want to describe what this is and what that meant for you guys and how you got it?" 16:00 "I'm assuming this potentially helped with the round of funding for Silicon Valley the Khosla Ventures round that you got, do you want to talk a little bit about this?" 20:00 "I have some questions about these first patients. It was done in Australia. Is there a difference or how does that work?" 22:00 "What are the plans for the future?" 25:45 "Do you have any ideas of how to be able to [have payers cover costs]?" 27:30 "We met each other at the bioelectronic medicine forum. Is this something that you've thought about?" 28:45 "I read that you guys have 60 patents. Is that true? And why so many?"   Eddie Chang's paper? https://www.frontiersin.org/articles/10.3389/fnhum.2021.714256/full

Today our expert guest is Dr. Nicholas Opie. He is a biomedical engineer with experience in neural prosthesis, co-head of the Vascular Bionics Laboratory, and Founder of pioneering endovascular bionics company Synchron, Inc. Vascular bionics combine biology and medical electronics in the bloodstream. Devices like stents and pacemakers are currently using blood vessels, and Dr. Opie sees these as an opportunity to access the brain without open brain surgery. These bionics have potential applications for individuals who suffer from paralysis, traumatic brain injuries, and degenerative diseases.   Making Technology Applicable  Too often, engineers and researchers create something fantastic that never reaches clinical use. Synchron is devoted to making these technological breakthroughs medically applicable. They're currently developing STENTRODE™, the world's first endovascular electrode array. It  is a minimally invasive implantable device designed to interpret signals from the brain, and Synchron is currently preparing for a pilot clinical trial of the device.  They plan to evaluate the safety and feasibility of the device to enable patient-directed brain control over mobility assist devices. He's confident people will be able to control wheel chairs and computers using the device, and his ambitious goal is that the technology will also allow people to control prosthetic limbs. In just the United States, there are about 6.9 million people who are paralyzed. “If we can help even a small fraction of those, then everything we're doing is worthwhile.”   The Biggest Helping: Today's Most Important Takeaway  If you enjoy what you do, then it's not working.   “That's what I like to live by. Everything I do is because it's something I enjoy and it's something I want to do. I think if everyone can take that bit of advice and do what they are passionate about, then their lives will be a lot happier and they'll have a great time doing it.”   -- Thank you for joining us on The Daily Helping with Dr. Shuster. Subscribe to the show on iTunes, Stitcher, or Google Play to download more food for the brain, knowledge from the experts, and tools to win at life.   Resources: Learn More: Vascular Bionics Laboratory | Synchron, Inc. Read through Dr. Opie's Reddit AMA (Ask Me Anything) on brain-controlled devices and neural implants